Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF460 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ZNF562 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | ZNF627 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ZNF644 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | ZNF654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZNF678 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ZNF700 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | ZNF80 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZNF800 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | ZNF804B | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |